Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

SEB Fund 3 - SEB Medical Fund

+ Add to Watchlist

SEBLOBB:LX

7.61 USD 0.02 0.20%

As of 00:59:30 ET on 05/27/2015.

Snapshot for SEB Fund 3 - SEB Medical Fund (SEBLOBB)

Year To Date: +10.66% 3-Month: +5.83% 3-Year: +26.43% 52-Week Range: 6.12 - 7.79
1-Month: -1.29% 1-Year: +24.49% 5-Year: +20.98% Beta vs NDWUHC: 0.98

Mutual Fund Chart for SEBLOBB

No chart data available.
  • SEBLOBB:LX 7.61
  • 1M
  • 1Y
Interactive SEBLOBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SEBLOBB

SEB Fund 3 - SEB Medical Fund is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests primarily in equities issued by pharmaceutical companies, biotechnical companies, medical technic or medical service companies, and companies active in health care.

Inception Date: 10-25-1993 Telephone: 352-2-66-82-1 Tel
Managers: ANDREAS HANSEN
Web Site: www.sebgroup.lu

Fundamentals for SEBLOBB

NAV (on 2015-05-27) 7.61
Assets (M) (on 2015-05-22) 69.38
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for SEBLOBB

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2013-05-24) 0.01
Dividend Yield (ttm) -

Fees & Expenses for SEBLOBB

Front Load -
Back Load 1.00
Current Mgmt Fee 1.50
Redemption Fee 1.00
12b1 Fee -
Expense Ratio 1.54

Top Fund Holdings for SEBLOBB

Filing Date: 03/31/2015
Name Position Value % of Total
Johnson & Johnson 43,415 4,367,549 6.516%
Roche Holding AG 15,209 4,198,147 6.264%
Gilead Sciences Inc 41,700 4,092,021 6.105%
Amgen Inc 22,967 3,671,275 5.478%
Novo Nordisk A/S 61,563 3,292,323 4.912%
AbbVie Inc 49,257 2,883,505 4.302%
Valeant Pharmaceuticals Intern 14,400 2,844,820 4.244%
Teva Pharmaceutical Industries 44,435 2,768,301 4.130%
Shire PLC 32,531 2,590,880 3.866%
AmerisourceBergen Corp 20,700 2,352,969 3.511%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil